364 results about "Instructions for use" patented technology

A system and method are disclosed for utilizing resources of a network. A constructive proof that a subset of resources is sufficient to satisfy the objective of a system can be generated. The constructive proof can comprise instructions for using the subset of resources. A set of computer-executable instructions can be created from the constructive proof and executed on a host device. The computer-executable instructions can control a data output device according to the instructions of the constructive proof.

An architecture and system are described that provide a unified file access service within in a managed computing environment composed of diverse networks, computing devices, and storage devices. The service provides mechanisms for remotely accessing the file systems of any managed computer or disk snapshot, independently of the computer's current state (powered on, suspended or powered off), its location within the environment, its hardware type (virtual vs. physical), its operating system type, and its file system formats. The system isolates centralized FPAs from the details of clients, proxies and storage elements by providing a service that decomposes offloaded file system access into two steps. A FPA or a requester acting on behalf of the FPA first expresses the disk set or the computer containing the file systems it wishes to access, along with requirements and preferences about the access method. The service figures out an efficient data path satisfying the FPA's needs; and then automatically configures a set of storage and computing resources to provide the data path. The service then replies with information about the resources and instructions for using them. The FPA then accesses the requested file systems using the returned information.

A system for service queue management is disclosed including a terminal controlled by the system having a processing platform to generate service queue information for a user, and a mechanism for the user to request or receive the service queue information. The processing platform preferably transmits promotions related to goods and services associated with the service queue information to a user. The mechanism for the user to request or receive service queue information may preferably include a user's mobile communications device or a manually-activated device located on the terminal. Service queue information may include a queue number, next queue number to be issued, estimated wait time for service, a predicted time of service, time of issuance of ticket, predicted queue-waiting time, marketing messages, instructions for use of said ticket dispenser, and average queue-waiting time.

The invention features catheters, hydrogel compositions, and methods that useful for the treatment of various conditions and diseases. The invention also provides kits and instructions for use.

One aspect of the invention provides an airway management device including: an endotracheal tube having a proximal end and a distal end and a sheath adjacent to the endotracheal tube. The sheath includes a proximal end and a distal end. The distal end of the endotracheal tube extends beyond the distal end of the sheath. Another aspect of the invention provides a surgical kit including an airway management device and instructions for use. The airway management device includes: an endotracheal tube having a proximal end and a distal end and a sheath adjacent to the endotracheal tube. The sheath includes a proximal and a distal end. The distal end of the endotracheal tube extends beyond the distal end of the sheath.

The present application provides methods of purifying polypeptides having a Fc region, for example, antibodies or antibody fusions, by adsorbing the polypeptides to a Fc binding agent, such as, for example, Protein A or Protein G, followed by a wash with a divalent cation salt buffer to remove impurities and subsequent recovery of the adsorbed polypeptides. The present application also features methods of eluting the purified polypeptide as well as the incorporation of the methods within a purification train. Kits comprising components for carrying out the methods and instructions for use are also provided.

A method for creating a set of virtual machines on a public datacenter. The method, from a first network controller of a private network, commands a second network controller of the public datacenter to create the virtual machines. The method, from the first network controller of the private network, communicates with the second network controller of the public datacenter to determine a type of the second network controller. When the first network controller includes instructions for using application programming interfaces (APIs) of the type of the second network controller, the method uses the APIs to set up a VLAN for the set of virtual machines in order to allow the virtual machines of the set of virtual machines to communicate securely with each other without sending the communications through the private network. In some embodiments, the VLAN is a private VLAN (PVLAN).

A storage device contains a smart-card device and a memory device, which is connected to a controller. The storage device may be used in the same manner as a conventional smart-card device, or it may be used to store a relatively large amount of data. The memory device may also be used to store data or instructions for use by the smart-card device. The controller includes a security engine that uses critical security parameters stored in, and received from, the smart-card device. The critical security parameters may be sent to the controller in a manner that protects them from being discovered. The critical security parameters may be encryption and/or decryption keys that may encrypt data written to the memory device and/or decrypt data read from the memory device, respectively. Data and instructions used by the smart-card device may therefore stored in the memory device in encrypted form.

The invention relates to cell stimulatory fusion proteins and DNA sequences, vectors comprising at least two agonists of TNF/TNFR super family, immunoglobulin super family, cytokine family proteins and optional antigen combination. Instructions for use of these proteins and DNA constructs as immune adjuvants and vaccines for treatment of various chronic diseases such as viral infection are also provided. Additionally, the use of these protein and DNA constructs as immune suppressant for treatment of various chronic diseases, such as autoimmunity and organ transplant rejection, is also illustrated.

A method, system, and computer instructions for using the language of the business domain to express subscriptions to a publish/subscribe messaging system. The resulting notifications sent to the subscriber are instances of the business model used to create the subscription. In other words, a subscriber may subscribe to the messaging system against the same information that the subscriber receives in a notification from the messaging system. The present invention uses the model from the business domain as the basis for notification subscriptions to allow for defining filters directly against the model's attributes, reducing problems caused by translating business models to a middleware description.

A method, system, and computer program instructions for using existing performance monitoring solutions to detect performance issues in an enterprise, and providing and executing a corrective action on any server being monitored in the enterprise to correct the performance issue. When a management agent on a monitored server detects a threshold violation, the management agent sends a violation event to the management server. Upon receiving the violation event, the management server distributes a corrective action associated with the threshold violation to a set of defined management agents involved in the transaction. Each management agent then runs the corrective action to remedy the performance problem.

A method for inhibiting hyperplasia at an anastomotic junction of a vascular fistula or vascular graft comprises exposing the anastomotic junction to vibrational energy at a mechanical index and for a time sufficient to inhibit hyperplasia. Kits are described comprising the catheter or a probe suitable for performing the methods together with instructions for use setting forth the methods. The methods and kits are particularly suitable for treating anastomotic junctions formed to provide vascular access for hemodialysis, hemofiltration, and the like. The methods and kits are also suitable for treating other vascular grafts, such as those formed during cardiac bypass graft surgery, vascular repair, and the like.

A kit for the rapid detection of pathogens in food supplies. The kit includes a microspot device and one or more indicator reagents to be applied to a well of the microspot device. The employed indicator reagent produces a detectable change upon contact with a pathogen of interest. The microspot device is fabricated from a porous membrane, such as filter paper. A substantially continuous boundary composed of a low melting temperature solid is deposited within the porous membrane extending from the top of the membrane to the bottom of the membrane and defines the peripheral sides of the well. Additionally, a barrier is applied to the bottom of the membrane, thus defining the bottom of the well. The kit can further include growth media for enriching the pathogenic bacteria and instructions for use of the kit employing the microspot device and the one or more indicator reagents.

Printed instructions (4000) can be included with the tray (100) in a medical procedure kit. The printed instructions (4000) can include instructional material (4202), such as pictorial, step-by-step instructions for using the medical procedure kit. The printed instructions (4000) can be configured as a booklet. The printed instructions (4000) can be adhesively attached to outer packaging (4201), and can include a peelable label (4402) that is separable from the printed instructions (4000) and is configured for attachment to medical records. Colorization of the various components can assist in ensuring safe usage of the medical procedure kit.

A method and data structures for use in providing diagnostics on-demand services are provided. A data structure is provided that identifies one or more server-side entry points for use by a client computer upon which diagnostics on-demand are to be performed. A data structure is also provided that identifies available diagnostics modules, their component files, and that provides installation instructions for use in retrieving and installing diagnostics modules. A method for providing diagnostics on-demand utilizing the data files is also provided.

Compounds and compositions for the transient expression of exogenous telomerase activity in a cell are provided. The compounds and compositions, which relate to a ribonucleic acid coding for a telomerase reverse transcriptase, are useful in the extension of telomeres in cells needing such treatment. Such cells include, for example, cells that contain shortened telomeres and cells from subjects that may benefit from telomere extension, for example subjects that suffer from, or are at risk of suffering from, age-related or other illnesses. Also provided are methods of extending telomeres through the administration of the provided compounds and compositions to animal cells, either in vitro or in vivo, and kits including the compounds or compositions and instructions for use.

The present invention provides preferred, preferably liquid, hard surface cleaning compositions, compositions with cleaning liquid composition on a substrate, compositions used with absorbent pads and implements and devices for making the process of cleaning hard surfaces and/or maintaining their appearance and hygiene easier and more effective. These compositions, along with specific instructions for use are advantageous for removal of and/or prevention of buildup of soils commonly encountered on floors, glass surfaces, counters, walls, showers and/or tubs, said compositions comprising hydrophilic polymers to render the cleaned surface hydrophilic and to improve the appearance when the surface is either not rinsed, or when the composition is incompletely removed, specific surfactant, preferably surfactant selected to minimize spotting/filming, optionally specific organic cleaning solvents to provide cleaning and wetting particularly in applications where levels of non-volatiles need to be minimized, and, optionally, anti-bacterial agents for preserving or surface activity and optionally perfumes for aesthetics.

This provides pharmaceutical compositions that comprise a combination of an anti-cancer agent which is an first antibody and a second antibody. In some embodiments, the first antibody is an anti-Programmed Death-1 (PD-1) antibody. In certain embodiments, the composition is a fixed dose formulation. In certain embodiments, the composition is administered as a flat-dose. The disclosure also provides a kit for treating a subject afflicted with a disease, the kit comprising a dosage of any composition disclosed herein and instructions for using the composition in any of the disclosed methods for treating a disease.

The invention features alginate and alginate lyase compositions and methods that are useful for the treatment of various conditions and diseases. The invention also provides kits and instructions for use.